Improve Life with Diabetes by Participating in Research
Your voice matters. Often the biggest changes in anything are the result of something initially small. People with diabetes are…
4 Things to Consider When Choosing a Health Insurance Plan
Finding and choosing a health insurance plan for an individual or a family faced with the medical demands and costs…
Breaking Down the Science: How We Make Change Happen
Emily’s Story: Using Nasal Glucagon to Treat Severe Hypoglycemia
Emily Marcum was excited to take her parents, John and Andrea, on a 10-mile walking tour of Manhattan and Brooklyn…
Breaking Down the Science: The T1D Exchange Health Equity Advancement Lab Program
With so much data being gathered during the pandemic, COVID-19 research has revealed the glaring severity of healthcare inequities in…
Breaking Down the Science: The T1D and COVID-19 Surveillance Study
In March of 2020, T1D Exchange quickly recognized — along with the rest of the country — that COVID-19 was…
Vertex Pharmaceuticals Pursues Investigational Cell Therapies for Type 1 Diabetes
In the fall of 2019, Vertex Pharmaceuticals Incorporated acquired Semma Therapeutics for $950 million. Founded by Douglas Melton, Ph.D. and…
Breaking Down the Science: All About The T1D Exchange Quality Improvement Collaborative (QIC)
Providing supportive care for those living with T1D is complex and comes with an ongoing responsibility of knowing how to…
Chatting with Dexcom CEO About the New G7, the Sampling Program, and the Patient Voice
There are approximately 900,000 people across the globe wearing a Dexcom continuous glucose monitor (CGM) today. “Up from 600,000 at…
Evaluating Telemedicine: Connecting Patient Voice to Research
While “telemedicine” certainly existed prior to the COVID-19 pandemic, it was simply an option for patients who preferred it or…
